{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:07:08Z","timestamp":1786997228480,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.surg.2022.05.005","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T21:20:15Z","timestamp":1663708815000},"page":"260-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Medullary thyroid cancer with RET V804M mutation: more indolent than expected?"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6777-0796","authenticated-orcid":false,"given":"Nicholas A.","family":"Frisco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander H.","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1561-9303","authenticated-orcid":false,"given":"Samantha M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Stang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall P.","family":"Scheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadiza S.","family":"Kazaure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2022.05.005_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1067\/msy.2002.123006","article-title":"V804M RET mutation and familial medullary thyroid carcinoma: report of a large family with expression of the disease only in the homozygous gene carriers","volume":"131","author":"Lecube","year":"2002","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2022.05.005_bib2","doi-asserted-by":"crossref","unstructured":"Wells SA, Asa SL, Dralle H, et\u00a0al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 25:567\u2013610.","DOI":"10.1089\/thy.2014.0335"},{"key":"10.1016\/j.surg.2022.05.005_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-08116-9","article-title":"Spectrum of Germline RET variants identified by targeted sequencing and associated multiple endocrine neoplasia type 2 susceptibility in China","volume":"21","author":"Qi","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.surg.2022.05.005_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","article-title":"Medullary thyroid cancer: management guidelines of the American Thyroid Association","volume":"19","author":"Kloos","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2022.05.005_bib5","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1089\/thy.2013.0620","article-title":"Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations","volume":"24","author":"Rich","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2022.05.005_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10689-016-9948-7","article-title":"All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients","volume":"16","author":"Long","year":"2017","journal-title":"Fam Cancer"},{"key":"10.1016\/j.surg.2022.05.005_bib7","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1210\/jc.2019-00516","article-title":"Long-term outcomes and aggressiveness of hereditary medullary thyroid carcinoma: 40 years of experience at one center","volume":"104","author":"Raue","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2022.05.005_bib8","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1210\/jc.2017-02529","article-title":"p.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer","volume":"103","author":"Loveday","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2022.05.005_bib9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.surg.2009.09.021","volume":"146","author":"Shifrin","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2022.05.005_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-021-02895-8","article-title":"Controversy on the management of patients carrying RET p.V804M mutation","volume":"75","author":"Alzahrani","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.surg.2022.05.005_bib11","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1067\/msy.2000.11\/6\/111080","article-title":"Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated?","volume":"128","author":"Frohnauer","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2022.05.005_bib12","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-019-07869-9","article-title":"Long-term oncologic outcomes after curative resection of familial medullary thyroid carcinoma","volume":"26","author":"Spanheimer","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2022.05.005_bib13","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/jmg.38.11.784","article-title":"Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET","volume":"38","author":"Kasprzak","year":"2001","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.surg.2022.05.005_bib14","doi-asserted-by":"crossref","first-page":"E509","DOI":"10.1210\/jc.2010-1234","article-title":"Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Fran\u00e7ais d\u2019Etude des Tumeurs Endocrines","volume":"96","author":"Rohmer","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2022.05.005_bib15","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/bjs.4718","article-title":"Germline RET V804M mutation associated with multiple endocrine neoplasia type 2A","volume":"91","author":"Gibelin","year":"2004","journal-title":"Br J Surg"},{"key":"10.1016\/j.surg.2022.05.005_bib16","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1210\/jc.2007-1005","article-title":"Brief report: RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center","volume":"92","author":"Elisei","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2022.05.005_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00125817-199901000-00023","article-title":"Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTGG\u2192ATG) mutation in two families: Reluctance of gene carriers to accept prophylactic thyroidectomy","volume":"1","author":"Feldman","year":"1999","journal-title":"Genet Med"},{"key":"10.1016\/j.surg.2022.05.005_bib18","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-2265.2005.02394.x","article-title":"Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations","volume":"63","author":"Learoyd","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.surg.2022.05.005_bib19","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1210\/jcem.87.4.8403","article-title":"Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804","volume":"87","author":"Lombardo","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2022.05.005_bib20","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/genes10090698","article-title":"Twenty-five years experience on RET genetic screening on hereditary MTC: an update on the prevalence of germline RET mutations","volume":"10","author":"Elisei","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.surg.2022.05.005_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/thy.2006.0198","article-title":"RET proto-oncogene in Sardinia: V804M is the most frequent mutation and may be associated with FMTC\/MEN-2A phenotype","volume":"17","author":"Pinna","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2022.05.005_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2265.2007.02830.x","article-title":"Asymptomatic bilateral adrenal pheochromocytoma in a patient with a germline V804M mutation in the RET proto-oncogene","volume":"67","author":"Recasens","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.surg.2022.05.005_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1245\/s10434-011-1795-z","article-title":"Simultaneous medullary and papillary thyroid cancer: a novel entity?","volume":"19","author":"Machens","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2022.05.005_bib24","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1245\/s10434-012-2357-8","article-title":"Simultaneous medullary and differentiated thyroid cancer: a population-level analysis of an increasingly common entity","volume":"19","author":"Wong","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2022.05.005_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12020-019-02183-6","article-title":"Calcitonin as a biomarker of C cell disease: recent achievements and current challenges","volume":"67","author":"Costante","year":"2020","journal-title":"Endocrine"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606022003233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606022003233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:03:42Z","timestamp":1758539022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606022003233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0039606022003233"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2022.05.005","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medullary thyroid cancer with RET V804M mutation: more indolent than expected?","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2022.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}